CAS 1575596-77-8

PRN1008

CAS : 1575596-77-8

Formule : C₃₆H₄₀FN₉O₃

Masse moléculaire : 665.77

Ref: 4Z-P-313001

PRN1008-d5

CAS : 1575596-77-8

Formule : C₃₆H₃₅D₅FN₉O₃

Masse moléculaire : 670.80

Ref: 4Z-P-313002

PRN-1008

Produit contrôlé

CAS : 1575596-77-8

Formule : C₃₆H₄₀FN₉O₃

Couleur et forme : Neat

Masse moléculaire : 665.76

Ref: TR-P745300

PRN-1008-d8

Produit contrôlé

CAS : 1575596-77-8

Formule : C₃₆D₈H₃₂FN₉O₃

Couleur et forme : Neat

Masse moléculaire : 673.809

Ref: TR-P745302

PRN-1008

CAS : 1575596-77-8

PRN-1008 is a small molecule inhibitor of the tyrosine kinase protein. It is designed to be reversible and covalent, which means that the drug will bind to the protein and it will not be able to function. PRN-1008 has been shown to inhibit chronic inflammation in animal models by blocking the enzyme phospholipase A2. The drug has also been shown to have therapeutic effects on hematological disorders such as leukemia, lymphoma, myeloid leukemia, myeloproliferative disorders, and myelodysplastic syndrome.

Formule : C₃₆H₄₀FN₉O₃

Degré de pureté : Min. 95%

Masse moléculaire : 665.8 g/mol

Ref: 3D-ANC59677